Table 2: Characteristics of patients technically feasible for quantitative analysis.

TotalNo LTPLTP
nnn value

Total18108
Age
 Mean (SD)64.9 (9.0)66.1 (10.7)63.4 (6.5)0.538
Sex
 Male1477.8%770.0%787.5%0.375
 Female422.2%330.0%112.5%
Cirrhosis presence
 Yes18100.0%10100.0%8100.0%
 No00.0%0No00.0%
Ascites presence
 Yes527.8%330.0%225.0%0.814
 No1372.2%770.0%675.0%
Etiology
 Hepatitis B0000.800
 Hepatitis C4220.410
 Alcohol abuse5230.180
 NASH2200.250
ECOG
 01794.4%10100.0%787.5%0.250
 115.6%0No112.5%
Child–Pugh score
 A950.0%550.0%450.0%1.000
 B950.0%550.0%450.0%
BCLC
 Very early633.3%330.0%337.5%0.737
 Early1266.7%770.0%562.5%
Lesion size
 Median in mm (range)22 (12–27)22 (12–27)22 (16–25)
OLTx <18 months
 Yes633.3%330.0%337.5%0.737
 No1266.7%770.0%562.5%
Distant intrahepatic recurrence
 Yes15.6%110.0%00.0%0.357
 No1794.4%990.0%8100.0%
RFA on target quantitative assessment
 Yes633.3%660.0%00.0%0.013
 No1266.7%440.0%8100.0%
RFA on target qualitative assessment
 Yes1688.9%10100.0%675.0%0.094
 No211.1%0225.0%
Year of RFA
 2009–2011738.9%220.0%562.5%0.066
 2012–20141161.1%880.0%337.5%

NASH = nonalcoholic steatohepatitis; ECOG = Eastern Cooperative Oncology Group; BCLC = Barcelona Clinic for Liver Cancer; RFA = radiofrequency ablation. More etiological factors could be present in one patient.